ELEVECTA™ stable producer cell line 2.0
For stable, inducible adeno-associated virus (AAV) production.
ELEVECTA™ producer cell line, 1.8 mL vial
ELEVECTAPCL
On request
Stock on request
Price includes standard shipping and handling
Overview
Our next generation of HEK‑based stable producer cell line for AAV manufacturing delivers stronger performance, accelerated development timelines, and a differentiated quality profile.
The ELEVECTA™ stable producer cell line 2.0 contains all genes to produce AAV; simply induce. The result is a simplified, robust upstream process that easily scales to treat hundreds of thousands.
- Simplified manufacturing process: single-step induction replaces complex transfection – just add inducer to start production, cutting complexity and timelines.
- Enhanced product quality: reduced encapsidated host cell DNA.
- Scalable from bench to production: consistent, high-quality AAV output from bench scale through large-scale manufacturing.
- Enhanced reproducibility: reliable, batch-to-batch AAV production with documented lineage.
- Lower cost of goods: eliminates plasmids and transfection reagents while simplifying operations to reduce manufacturing costs.
Contact us at ELEVECTA@cytiva.com to speak directly to our specialists.
Product specifications
Showing 1 products
ELEVECTA™ producer cell line, 1.8 mL vial
ELEVECTAPCL
Stock on request
On request
Product availability is not guaranteed and subject to change.
